Terms: = Lung cancer AND PMS1, hPMS1, 5378, ENSG00000064933, PMSL1, HNPCC3, DKFZp781M0253 AND Treatment
3 results:
1. Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma.
Losi L; Bertolini F; Guaitoli G; Fabbiani L; Banchelli F; Ambrosini-Spaltro A; Botticelli L; Scurani L; Baldessari C; Barbieri F; Cascinu S; Maiorana A
Int J Oncol; 2019 Nov; 55(5):1157-1164. PubMed ID: 31545419
[TBL] [Abstract] [Full Text] [Related]
2. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I
Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356
[TBL] [Abstract] [Full Text] [Related]
3. Semiquantitative visual approach to scoring lung cancer treatment response using computed tomography: a pilot study.
Gottlieb RH; Kumar P; Loud P; Klippenstein D; Raczyk C; Tan W; Lu J; Ramnath N
J Comput Assist Tomogr; 2009; 33(5):743-7. PubMed ID: 19820504
[TBL] [Abstract] [Full Text] [Related]
